About 40 Mg Enoxaparin Sodium Injection IP
Discover the highlighted 40 Mg Enoxaparin Sodium Injection IP-a transcendent masterpiece in anticoagulant therapy, commonly ace-marketed under renowned brands like Clexane and Lomoh. Designed for subcutaneous administration, this clear-to-pale yellow solution offers a special rate with limited stock exclusively for healthcare professionals. Its potent formula (C26H40N2O36S5) ensures reliable prevention and treatment of DVT, pulmonary embolism, and in perioperative care. Approved by DCGI and meeting Indian Pharmacopeia standards, each pre-filled syringe is your assurance of safety and efficacy-making it the supreme choice for life-saving interventions.
Material Features and Clinical Applications
The 40 Mg Enoxaparin Sodium Injection IP is highlighted for its purity and precision, derived from premier pharmaceutical materials. It is ideally suited for preventing and managing deep vein thrombosis and pulmonary embolism in adults, particularly before and after surgery. This ace solution stands out for its extended shelf life of 24 months and ease of administration via subcutaneous injection, ensuring streamlined patient care across clinical setups.
Sample Policy, Certifications, and Packaging Details
Upon arrival, each export-quality injection is meticulously drop-off-ready, packaged in a sterile, single-use pre-filled syringe, and encased in robust outer packaging for secure transport. Our special sample policy accommodates distributors and traders, providing access to trial quantities upon request. The product is certified as per Indian Pharmacopeia and regulatory protocols, guaranteeing quality and authenticity from dispatch to delivery.
FAQ's of 40 Mg Enoxaparin Sodium Injection IP:
Q: How should the 40 Mg Enoxaparin Sodium Injection IP be stored before usage?
A: Store the injection below 25C, protected from light and moisture, to maintain the efficacy and stability of the solution.
Q: What are the main clinical benefits of using this enoxaparin sodium injection?
A: It is primarily used for the prevention and treatment of deep vein thrombosis (DVT), pulmonary embolism, and as an anticoagulant during and after surgery, reducing the risk of blood clots.
Q: When is this injection contraindicated?
A: This product must not be used in patients with active major bleeding or those with known hypersensitivity to enoxaparin or heparin.
Q: Where is the 40 Mg Enoxaparin Sodium Injection IP manufactured and under which regulatory standards?
A: This injection is manufactured in India under Indian Pharmacopeia (IP) standards, holding approval from the Drug Controller General of India (DCGI).
Q: What is the recommended process for administering this medicine?
A: Administration should follow a healthcare professional's guidance, typically as a once-daily subcutaneous injection.
Q: What packaging is used for safe delivery and compliance?
A: Each box contains one sterile, ready-to-use pre-filled syringe, securely packaged to maintain product integrity during transport.